These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8995003)

  • 1. Smoking and postmenopausal hormone replacement therapy.
    Jensen J
    Br J Clin Pract Suppl; 1996 Sep; 86():6-8. PubMed ID: 8995003
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical markers of bone metabolism in postmenopausal women--the effect of hormone replacement therapy and smoking.
    Kusec V; Stavljenić Rukavina A; Cubrilo Turek M
    Croat Med J; 1998 Mar; 39(1):23-7. PubMed ID: 9475803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renewing the recognition on benefit and risk of long-term hormone replacement therapy in postmenopausal women].
    Zhang YW
    Zhonghua Fu Chan Ke Za Zhi; 2003 Aug; 38(8):487-8. PubMed ID: 14627037
    [No Abstract]   [Full Text] [Related]  

  • 4. Postmenopausal hormone replacement therapy: does the progestin make a difference?
    Fylstra DL
    J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
    [No Abstract]   [Full Text] [Related]  

  • 5. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of smoking on estradiol metabolism.
    Tansavatdi K; McClain B; Herrington DM
    Minerva Ginecol; 2004 Feb; 56(1):105-14. PubMed ID: 14973414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women.
    Bjarnason NH
    Dan Med Bull; 2005 May; 52(2):64-81. PubMed ID: 16009050
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
    Kovacev-Zavisić B; Icin T; Kovacev N
    Med Pregl; 2009; 62 Suppl 3():85-90. PubMed ID: 19702123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause.
    Birkhäuser MH; Panay N; Archer DF; Barlow D; Burger H; Gambacciani M; Goldstein S; Pinkerton JA; Sturdee DW
    Climacteric; 2008 Apr; 11(2):108-23. PubMed ID: 18365854
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hormone replacement therapy after menopause].
    Emons G
    Dtsch Med Wochenschr; 2001 Mar; 126(9):253-4. PubMed ID: 11256041
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis].
    Brettes JP; Mathelin C
    Gynecol Obstet Fertil; 2007 Nov; 35(11):1092-4. PubMed ID: 17996474
    [No Abstract]   [Full Text] [Related]  

  • 13. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?
    Mikkola TS; Clarkson TB; Notelovitz M
    Ann Med; 2004; 36(6):402-13. PubMed ID: 15513292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implication of hormone treatment in postmenopausal kidney transplants.
    Hung CJ; Lee PC; Song CM; Chang YT; Tsai MT; Dai YS; Chen EJ; Lei HY; Lee PH; Lee CJ
    Transplant Proc; 1996 Jun; 28(3):1548-50. PubMed ID: 8658780
    [No Abstract]   [Full Text] [Related]  

  • 15. Postmenopausal hormone replacement therapy for the primary prevention of chronic conditions: recommendations and rationale.
    Berg AO;
    Am J Nurs; 2003 Jun; 103(6):83-91. PubMed ID: 12802162
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are oestrogen deficiency and hormone replacement a distraction to the field of osteoporosis?
    Kanis JA
    Osteoporos Int; 1998; 8 Suppl 1():S51-6. PubMed ID: 9682799
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormone replacement therapy in postmenopausal women.
    Prelevic GM; Kocjan T; Markou A
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Some problems of postmenopausal osteoporosis prevention with hormone replacement therapy].
    Liu JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):240-3. PubMed ID: 12905731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health risks after cessation of postmenopausal hormone therapy.
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.